GT
Healthcare & Life Sciences
Geneos Therapeutics
United States
Geneos Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Geneos Therapeutics
Based in the United States, Geneos Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Geneos Therapeutics develops GT-EPIC™, a platform for generating personalized cancer immunotherapies targeting tumor-specific neoantigens, focusing on solid tumors such as hepatocellular carcinoma with demonstrated clinical responses in a Phase Ib/IIa trial.
Explore Geneos Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.